262 related articles for article (PubMed ID: 27102560)
1. Autophagy induced by exogenous bile acids is therapeutic in a model of α-1-AT deficiency liver disease.
Tang Y; Fickert P; Trauner M; Marcus N; Blomenkamp K; Teckman J
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G156-65. PubMed ID: 27102560
[TBL] [Abstract][Full Text] [Related]
2. NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.
Tang Y; Blomenkamp KS; Fickert P; Trauner M; Teckman JH
PLoS One; 2018; 13(8):e0200897. PubMed ID: 30067827
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin reduces intrahepatic alpha-1-antitrypsin mutant Z protein polymers and liver injury in a mouse model.
Kaushal S; Annamali M; Blomenkamp K; Rudnick D; Halloran D; Brunt EM; Teckman JH
Exp Biol Med (Maywood); 2010 Jun; 235(6):700-9. PubMed ID: 20511674
[TBL] [Abstract][Full Text] [Related]
4. Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.
Brunt EM; Blomenkamp K; Ahmed M; Ali F; Marcus N; Teckman J
J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):626-30. PubMed ID: 20890217
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency.
Rudnick DA; Shikapwashya O; Blomenkamp K; Teckman JH
Hepatology; 2006 Oct; 44(4):976-82. PubMed ID: 17006946
[TBL] [Abstract][Full Text] [Related]
6. FBG1 Is the Final Arbitrator of A1AT-Z Degradation.
Wen JH; Wen H; Gibson-Corley KN; Glenn KA
PLoS One; 2015; 10(8):e0135591. PubMed ID: 26295339
[TBL] [Abstract][Full Text] [Related]
7. Alpha-1-antitrypsin mutant Z protein content in individual hepatocytes correlates with cell death in a mouse model.
Lindblad D; Blomenkamp K; Teckman J
Hepatology; 2007 Oct; 46(4):1228-35. PubMed ID: 17886264
[TBL] [Abstract][Full Text] [Related]
8. Alpha-1 antitrypsin and liver disease: mechanisms of injury and novel interventions.
Teckman JH; Mangalat N
Expert Rev Gastroenterol Hepatol; 2015 Feb; 9(2):261-8. PubMed ID: 25066184
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency.
Pastore N; Blomenkamp K; Annunziata F; Piccolo P; Mithbaokar P; Maria Sepe R; Vetrini F; Palmer D; Ng P; Polishchuk E; Iacobacci S; Polishchuk R; Teckman J; Ballabio A; Brunetti-Pierri N
EMBO Mol Med; 2013 Mar; 5(3):397-412. PubMed ID: 23381957
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency.
Teckman JH; An JK; Blomenkamp K; Schmidt B; Perlmutter D
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G851-62. PubMed ID: 14684378
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of Alpha-1 Antitrypsin Deficiency Liver Disease.
Teckman JH; Blomenkamp KS
Methods Mol Biol; 2017; 1639():1-8. PubMed ID: 28752441
[TBL] [Abstract][Full Text] [Related]
12. Targeting intracellular degradation pathways for treatment of liver disease caused by α1-antitrypsin deficiency.
Wang Y; Perlmutter DH
Pediatr Res; 2014 Jan; 75(1-2):133-9. PubMed ID: 24226634
[TBL] [Abstract][Full Text] [Related]
13. Survival Advantage of Both Human Hepatocyte Xenografts and Genome-Edited Hepatocytes for Treatment of α-1 Antitrypsin Deficiency.
Borel F; Tang Q; Gernoux G; Greer C; Wang Z; Barzel A; Kay MA; Shultz LD; Greiner DL; Flotte TR; Brehm MA; Mueller C
Mol Ther; 2017 Nov; 25(11):2477-2489. PubMed ID: 29032169
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA
Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872
[TBL] [Abstract][Full Text] [Related]
15. Bile Duct Ligation Induces ATZ Globule Clearance in a Mouse Model of α-1 Antitrypsin Deficiency.
Khan Z; Yokota S; Ono Y; Bell AW; Oertel M; Stolz DB; Michalopoulos GK
Gene Expr; 2017 Feb; 17(2):115-127. PubMed ID: 27938510
[TBL] [Abstract][Full Text] [Related]
16. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency.
Rudnick DA; Liao Y; An JK; Muglia LJ; Perlmutter DH; Teckman JH
Hepatology; 2004 Apr; 39(4):1048-55. PubMed ID: 15057909
[TBL] [Abstract][Full Text] [Related]
17. Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.
Greene CM; Miller SD; Carroll T; McLean C; O'Mahony M; Lawless MW; O'Neill SJ; Taggart CC; McElvaney NG
J Inherit Metab Dis; 2008 Feb; 31(1):21-34. PubMed ID: 18193338
[TBL] [Abstract][Full Text] [Related]
18. Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency.
Lawless MW; Greene CM; Mulgrew A; Taggart CC; O'Neill SJ; McElvaney NG
J Immunol; 2004 May; 172(9):5722-6. PubMed ID: 15100318
[TBL] [Abstract][Full Text] [Related]
19. Pi*Z heterozygous alpha-1 antitrypsin states accelerate parenchymal but not biliary cirrhosis.
Cacciottolo TM; Gelson WT; Maguire G; Davies SE; Griffiths WJ
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):412-7. PubMed ID: 24518491
[TBL] [Abstract][Full Text] [Related]
20. Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis.
Beraza N; Ofner-Ziegenfuss L; Ehedego H; Boekschoten M; Bischoff SC; Mueller M; Trauner M; Trautwein C
Gut; 2011 Mar; 60(3):387-96. PubMed ID: 21115542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
